Event date: 15.10.2026
Following CE marking for NOAH, OxyPrem is now preparing for commercialisation across Europe. NeuroLF by Positrigo has become the first dedicated brain PET system to achieve EARL accreditation, which promotes the harmonisation and standardisation of PET imaging across centres in Europe.
18.09.2026
Last year Swiss-UK Medtech startup Aseptuva raised CHF 2.4 million from prominent healthcare entrepreneurs and investors. The financing has enabled Aseptuva to progress from early prototyping to preclinical validation in Europe.
31.10.2025
BIO-Europe is the leading trade fair for the biotechnology industry across Europe and beyond, bringing together industry players in biotech, pharma as well as emerging tech companies and investors to explore latest trends and forge partnerships. Scheduled to take place from November 3-5, the event will feature a broad range of Swiss startups, among them Technopark Zurich resident cellvie.
12.09.2025
cellvie, a pioneer in mitochondrial-based therapeutics, has secured fresh funding from both existing and new investors. With the additional capital, cellvie will accelerate the clinical translation of its lead program in kidney transplantation, and to further hone its pipeline.
04.07.2025
Twenty-three startups, among them our resident Arbrea Labs, made it to the second phase of Innosuisse’s Scale-up Coaching program, unlocking an additional voucher of up to CHF 75’000 that can be redeemed for further coaching sessions. The companies are developing solutions across a range of industries, including medtech, ICT, industrial machinery and cleantech.